title: [Clinical features of 23 cases of AIDS complicated by tuberculosis].
abstract: OBJECTIVE
  To discuss the clinical features, treatment and prognosis of patients with AIDS complicated by tuberculosis(TB).
  
  
  METHODS
  The clinical features of 23 patients with AIDS complicated by tuberculosis admitted from 1997 to July 2004 were retrospectively analyzed.
  
  
  RESULTS
  Of the 23 patients, most (94.3%) were young or middle-aged, and 11 (47.8%) died within half a year. The main HIV transmission was via sexual contact in 15 (65.2%) patients. Loss of body weight by 5 - 15 kg was present in all patients, cough for over 1 month in 15 (65.2%), and multiple opportunistic infections were complicated in most cases. Out of the 23 cases, 14 (60.9%) showed only pulmonary TB, and 8 (34.8%) showed lymph node TB. In 12 cases with infiltrated pulmonary TB, X-ray showed bilateral infiltration and no cavity formation was found. Slightly positive PPD test was found in 2 (8.7%) cases, and positive acid-fast bacilli was detected in sputum in 1 case (4.4%). The pre-treatment CD(4)(+) cell number in 23 patients was much lower than that in AIDS patients without complicated TB (P < 0.05). The pre-treatment CD(4)(+) cell number in patients died shortly after diagnosis was much lower than that in survived patients (P < 0.05). The HIV RNA level in the 23 patients was much higher than that in patients without complication of TB (P < 0.05). The mortality in patients treated with therapy against both TB and HIV was much lower than that in patients untreated or treated only with anti-TB therapy (P < 0.05).
  
  
  CONCLUSIONS
  For patients with AIDS complicated by TB, the high negative rate in PPD test and the atypical chest X-ray manifestations are common. However, lymph node TB is quite common with high mortality. The pre-treatment CD(4)(+) level decreases significantly, and is associated with mortality. The TB bacilli may accelerate HIV virus duplication. It is suggested that the patients be treated with a combination of anti-TB and anti-HIV therapies.
authors.affiliation: Department of Tuberculosis, Shenzhen East Lake Hospital, Shenzhen 518020, China.
authors.forename: Jing
authors.initials: J
authors.lastname: Yuan
authors.forename: Wei-Ye
authors.initials: WY
authors.lastname: Yu
authors.forename: Yi-Wen
authors.initials: YW
authors.lastname: Hu
authors.forename: Xiao-Ling
authors.initials: XL
authors.lastname: Jiang
authors.forename: Zi-Yi
authors.initials: ZY
authors.lastname: Luo
authors.forename: Bin
authors.initials: B
authors.lastname: Wen
authors.forename: Yan
authors.initials: Y
authors.lastname: Liu
authors.forename: Ming
authors.initials: M
authors.lastname: Wu
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000890:Anti-Infective Agents; D000995:Antitubercular Agents